This article was originally published in The Gray Sheet
Allegiance Healthcare rounds out existing line of Tru-Cut and Jamshidi manual and fully automated biopsy devices via the March 26 purchase of privately held Bauer Medical, which markets the Temno family of semi-automated and fully automated biopsy systems, needles, bone and bone-marrow biopsy instruments. Clearwater, Florida-based Bauer has annual revenues of $5-10 mil. and is headed by founder Alberto Bauer, company President Tony Hanson, and Director of Marketing and Sales Dennis Feldman. Founded in 1989, Bauer has about 70 employees, of which six comprise the firm's direct sales organization. Allegiance currently has 15 direct sales reps responsible for its biopsy products line. Bauer's principal manufacturing facility is located in the Dominican Republic. Financial details of the all-cash transaction were not disclosed
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.